Biotech Startups

MasterSwitch Bio is developing master transcription therapy aimed at rescuing end-stage organs.

1 investor

Material Futures develops all-natural colours produced by microorganisms.

1 investor

Materia Medica Processing is an Italian pharmaceutical company authorized by the Ministry of Health to distribute and produce cannabis-derived active pharmaceutical ingredients (APIs) for medical use, supplying pharmacies for magistral preparations under medical prescription. Operating GMP laboratories, it imports plant substances and extracts from qualified European suppliers and serves pharmacies, physicians, and patients.

1 investor

Animate Biosciences develops peptide therapeutics that target pathological tissue remodeling, using an AI-powered platform that applies multi-omic data from highly regenerative organisms to design novel peptides. The company aims to treat conditions involving tissue and organ degeneration that currently have limited or no effective treatments.

1 investor

Mati makes plant-based meat alternatives such as a chicken substitute made from mycelium (mushroom root structure) grown through fermentation, high in protein and fiber. Its products are marketed as sustainable food that suits any dish or world cuisine, with additional items like a fish alternative in development.

1 investor

Matridx (杰毅生物) develops molecular diagnostics for infectious diseases, combining high-throughput sequencing (NGS) and CRISPR/Cas gene-editing platforms with big-data analysis and AI to provide clinical diagnostic solutions. Its automated lab systems detect nearly 200 pathogens and 15 common drug-resistance genes, serving clinicians diagnosing and treating infectious diseases.

1 investor

Matwings is an AI-driven protein research platform that combines large-scale protein sequence datasets with a proprietary large language model for precise functional protein design. The platform automates the entire workflow from drug discovery and agricultural applications to biofabricated materials, serving pharmaceutical, biotechnology, and agribusiness sectors.

1 investor

Maven Bio provides software for biotech investment firms to accelerate due diligence and thesis development, automating screening, competitive analysis, and clinical data review to compress research timelines from days to hours.

1 investor

A content site publishing Russian-language reviews and articles about biotechnology, focusing on engineered bacteria and enzymes for plastic degradation and recycling. It covers the opportunities and risks of using biological methods to complement mechanical recycling of polymers such as PET and polyurethanes.

1 investor

Mavios provides an AI-native platform that integrates deep bioprocess knowledge and unified intelligence to bridge the gap between biological research capabilities and large-scale industrial production. The platform serves biomanufacturing teams working on food, health, materials, and medicine innovations.

1 investor

The Max Planck Florida Institute (MPFI) is a neuroscience research organization studying the nervous system, from molecules to synaptic networks, to understand brain development, function, and health. Its work spans perception, memory, emotion, and other brain functions.

1 investor

MaxCyte develops non-viral electroporation and cell-engineering technology used to transfect and engineer cells for research and therapeutic development. It also offers gene editing risk assessment services and licensing partnerships to help cell and gene therapy developers advance toward clinical and commercial stages.

1 investor

Maya Milk engineers and optimizes microbial yeast strains for precision fermentation, enabling food companies to produce animal-free dairy proteins and fats such as whey protein. It serves dairy and alternative-protein producers in the foodtech industry, with R&D operations in Izmir, Turkey.

1 investor

1 investor

mbiomics designs and develops complex Live Biotherapeutic Products (LBPs) based on gut microbiome consortia to treat severe and chronic diseases, with a pipeline spanning oncology (melanoma, NSCLC/renal cell carcinoma), IBD, and ASD. The company combines a data science platform, a proprietary strain library, co-culturing manufacturing, and screening analytics to design and produce indication-specific microbial therapeutics.

1 investor

M-box provides digital tools to help individuals manage over-the-counter medication use safely and effectively for self-medication and disease prevention. The company supports sustainable healthcare systems by addressing gaps in medication selection and user guidance.

1 investor

mBrace Therapeutics is a therapeutics company focused on drug development, led by executives with backgrounds in oncology and pharmaceutical business development.

1 investor

Biotechnology company developing treatments for ophthalmic diseases, focusing on dry eye through a topical ophthalmology platform.

1 investor

UT MD Anderson is a cancer research and treatment center that provides patient care, conducts research, and offers education in cancer prevention and treatment. It is part of the University of Texas System and operates as a nonprofit medical institution.

1 investor

Meadowhawk Biolabs is a contract research organization providing non-GLP bioanalytical and in vivo services—including LCMS bioanalysis, immunoanalysis, molecular analysis, and rodent pharmacology—for early-stage drug development programs. It serves pharmaceutical and biotech clients across drug modalities, operating out of Boston and San Francisco life science hubs.

1 investor

Meat Tomorrow is a cellular agriculture company developing methods to produce affordable, sustainable cultivated meat as an alternative to conventional animal-based meat production. It is based in Copenhagen, Denmark.

1 investor

1 investor

Mechanica is a company builder that creates biotechnology startups at the intersection of computational biology, AI, and drug discovery. It develops new companies, builds shared infrastructure, and accumulates biological insight across its programs.

1 investor

MeCo Diagnostics develops diagnostic solutions for cancer detection and management. The company works with healthcare institutions and oncology professionals to improve patient outcomes.

1 investor